Respiratory research

Building on our 45 year heritage in respiratory research, we remain relentless in our pursuit to improve the outcomes for patients with asthma and COPD.

Lady in Lab with microscope (Wavre)

Alongside inhaled approaches, where the focus is on helping patients achieve good control of their symptoms, we are developing the next generation of treatments – novel biologics and medicines that target the underlying causes of disease. Beyond asthma and COPD, we are actively exploring treatments for other respiratory diseases, such as idiopathic pulmonary fibrosis and acute lung injury. 

In the future, improvements in the treatment of respiratory diseases will come not only from new medicines but also from innovations in patient care, including adherence and treatment personalisation.”

Our pipeline
ipad technology reading

Product development pipeline

Download our full product development pipeline

Close up of lab equipment (Wavre)

Working in Respiratory R&D

Meet our people and hear what it's like to work in GSK R&D

Meet our people